We create better, smarter, faster ways to help biopharmaceutical clients drive their products from lab to life.
We know what you are up against and what it takes to succeed in a changing market of increasing complexity.
Payers, physicians and patients want results – and so do you.
Companies need a partner that can challenge the status quo and generate results.
We are constantly looking for ways to break down barriers to help get your product to market as efficiently and quickly as possible.
inVentiv Health is the partner that accelerates the clinical and commercial success of biopharmaceutical companies worldwide.
Campbell Alliance Survey of Biopharmaceutical Dealmakers Suggests 2015 Will Set a New Record for M&A LicensingClick Here to View Survey Results
inVentiv Health Names Dr. Michael McKelvey President, Clinical Division and Vice President, inVentiv HealthClick Here to View Press Release
Year Before Europe’s New Clinical Trials Regulation Take Effect, Pharma Companies Must Prepare for a Tough Compliance Challenge | Pharmaceutical Compliance MonitorClick Here to Read the Article
Read Live Insights from Our Team On the Ground at Cannes Lions Health – June 19 & 20
inVentiv Health experts helping global clients realize their goals in clinical development and commercialization
Countries in which inVentiv Health supports our clients
Global pharmaceutical companies have turned to inVentiv Health for expertise, skills and insight.
of all drugs approved by the FDA in recent years have been developed or commercialized by inVentiv Health
of all New Molecular Entities, or two-thirds of all truly novel drugs, have benefited from inVentiv Health’s clinical or commercial expertise
of cardiovascular drugs approved by the FDA have been developed or commercialized by inVentiv Health
of oncology drugs approved by the FDA have received assistance from inVentiv Health experts